|
Press Releases |
|
|
|
Friday, March 29, 2024 |
|
乐普生物2023年收入快速增长,亏损大幅收窄,ADC进入收获期 |
more info >> |
|
樂普生物2023年收入快速增長,虧損大幅收窄,ADC進入收穫期 |
more info >> |
|
Friday, August 25, 2023 |
|
乐普生物公布2023年中期业绩 |
聚焦于肿瘤治疗领域的创新型生物制药公司──乐普生物科技股份有限公司(「乐普生物」或「公司」,股份代号:2157.HK),于今日公布2023年中期业绩。 more info >> |
|
樂普生物公佈2023年中期業績 |
聚焦於腫瘤治療領域的創新型生物製藥公司──樂普生物科技股份有限公司(「樂普生物」或「公司」,股份代號:2157.HK),於今日公佈2023年中期業績。 more info >> |
|
Friday, March 17, 2023 |
|
乐普生物公布2022年度业绩 |
聚焦于肿瘤治疗领域的创新型生物制药公司──乐普生物科技股份有限公司(「乐普生物」或「公司」,股份代号:2157.HK),于今日公布2022年度业绩。 more info >> |
|
樂普生物公佈2022年度業績 |
聚焦於腫瘤治療領域的創新型生物製藥公司──樂普生物科技股份有限公司(「樂普生物」或「公司」,股份代號:2157.HK),於今日公佈2022年度業績。 more info >> |
|
Thursday, February 23, 2023 |
|
乐普生物和康诺亚共同宣布与阿斯利康就CMG901达成全球独家授权协议 |
乐普生物科技股份有限公司 (HK:02157)和康诺亚生物医药科技有限公司(HK:02162)今日共同宣布与阿斯利康(AstraZeneca,LSE/STO/纳斯达克:AZN)就潜在世界首创Claudin 18.2抗体偶联药物CMG901达成全球独家授权协议。 more info >> |
|
樂普生物和康諾亞共同宣佈與阿斯利康就CMG901達成全球獨家授權協定 |
樂普生物科技股份有限公司 (HK:02157)和康諾亞生物醫藥科技有限公司(HK:02162)今日共同宣佈與阿斯利康(AstraZeneca,LSE/STO/納斯達克:AZN)就潛在世界首創Claudin 18.2抗體偶聯藥物CMG901達成全球獨家授權協定。 more info >> |
|
Lepu Biopharma and Keymed Jointly Announces Global Exclusive Licence Agreement with AstraZeneca for CMG901 |
On 23 February, 2023, Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate (ADC). more info >> |
|
Thursday, September 29, 2022 |
|
乐普生物PD-1单抗普佑恒(TM)获批新适应症,MRG003获CDE纳入突破性治疗药物名单 |
乐普生物科技股份有限公司 (「乐普生物」或「公司」,股份代号:2157.HK) 宣布,公司旗下首款创新型生物药抗PD-1抗体——普佑恒™(通用名:普特利单抗注射液)已获得国家药品监督管理局(NMPA)批准上市销售。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Armor Unveils a Disruptive Approach to Managed Detection and Response
May 6, 2024 23:00 HKT/SGT
|
|
|
CyberSecID Conference 2024 - Zero Trust for Today, Zero Worries for Tomorrow
May 6, 2024 22:00 HKT/SGT
|
|
|
Lexaria Announces New Research Program to Evaluate Mode of Action and Performance of DehydraTECH-GLP-1 Drugs
May 6, 2024 21:05 HKT/SGT
|
|
|
义合控股(1662.HK)旗下附属公司APEL于日内瓦国际发明展勇夺三奖
May 6, 2024 18:57 HKT/SGT
|
|
|
義合控股(1662.HK)旗下附屬公司APEL於日內瓦國際發明展勇奪三獎
May 6, 2024 18:53 HKT/SGT
|
|
|
Yee Hop Holdings' (1662.HK) Subsidiary APEL Triumphs with Three Medals at the International Exhibition of Inventions Geneva
May 6, 2024 18:42 HKT/SGT
|
|
|
2024 CAP Consumer Survey Shows Increase in Piracy on Social Media and Messaging Platforms in Asia Pacific
May 6, 2024 18:00 HKT/SGT
|
|
|
SMEStreet Celebrates 10 Years of Serving Indian MSMEs
May 6, 2024 17:20 HKT/SGT
|
|
|
World Blockchain Summit: Pioneering Insights and Strategic Partnerships Ignite in Dubai
May 6, 2024 16:50 HKT/SGT
|
|
|
Future of Video in India Sees Much Optimism for Growth with Technology as the Enabler for the Consumer
May 6, 2024 15:40 HKT/SGT
|
|
|
Rockbird media Presents Retail & E-commerce Summit Asia 2024 - 'Retail Revolution: Setting the Landscape Ablaze' in Manila
May 6, 2024 15:00 HKT/SGT
|
|
|
綠竹生物:2023年度業績發表會圓滿舉行
May 6, 2024 14:00 HKT/SGT
|
|
|
Rockbird media Presents HR Leaders & HR Tech Strategy Meeting 2024: 'Rehumanizing Work with Emerging Technologies' in Manila
May 6, 2024 14:00 HKT/SGT
|
|
|
绿竹生物:2023年度业绩发布会圆满举行
May 6, 2024 13:55 HKT/SGT
|
|
|
CropLife Asia announces new Office Bearers for 2024
May 6, 2024 13:00 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|